Ticker

Merck said it is offering $20 in cash for each American depositary share for Nasdaq-listed Silence Therapeutics, more than double the target's closing price as of Friday.

Merck KGaA (OTCMKTS:MKGAF - Get Free Report)'s share price gapped down before the market opened on Monday. The stock had previously closed at $160.7520, but opened at $153.9040. Merck KGaA shares last traded at $158.9760, with a volume of 127 shares traded. Merck KGaA Stock Performance The company has a debt-to-equity ratio of 0.27, a

Beacon Pointe Advisors LLC bought a new stake in Merck KGaA (OTCMKTS:MKGAF) in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 363,066 shares of the company's stock, valued at approximately $46,655,000. Beacon Pointe Advisors LLC owned about

Blue Edge Capital LLC lowered its holdings in Merck KGaA (OTCMKTS:MKGAF) by 39.1% in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 11,499 shares of the company's stock after selling 7,392 shares during the period. Blue Edge Capital LLC's

Bamco Inc. NY purchased a new position in shares of Merck KGaA (OTCMKTS:MKGAF) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 22,000 shares of the company's stock, valued at approximately $2,827,000. Other hedge funds and other institutional investors